+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Xyrem 2020 U.S. Promotional Audit Report

  • ID: 5387161
  • Report
  • July 2021
  • Region: United States
  • 32 pages
  • MD Details
The 5 Key Questions Addressed by this Report:
  • How many physicians were reached by Xyrem through reportable promotional activity in 2020 and how does this compare to its peer set in the Cataplexy and Narcolepsy markets?
  • What promotional mix was leveraged (e.g., sales rep detailing, physician education, and paid speaking) and what was the median spend for each type of activity?
  • How does Jazz's depth of coverage vary within key specialties (e.g., Pulmonology, Neurology, Psychiatry, Family Medicine, Internal Medicine, Sleep Medicine, Pediatric Medicine, and Critical Care Medicine) and how does this compare to its peers and the overall set of rep-accessible physicians?
  • How often are physicians receiving paid meals for Xyrem throughout the year (e.g., monthly, quarterly, annually)?
  • Who were the most frequent meal recipients and top paid speakers for Xyrem in 2020?
Data Sources and Methodology:
  • Author leverages company-reported financial transaction data disclosed through CMS Open Payments. This data set captures all transfers of value (e.g., speaking fees, consulting fees, travel, education, and meals) made on behalf of a drug or device manufacturer to a physician. More than five years of longitudinal data is available - covering payments to more than 1,000,000 U.S. healthcare professionals.
  • Over 4,100 paid interactions across 2,100 physicians made on behalf of Xyrem were carefully examined to support our analysis. In addition, interaction data from 3 peer products (i.e. Sunosi, Wakix, and Xywav) was leveraged to provide benchmarking and market insights.
Note: Product cover images may vary from those shown
Adroll
adroll